MedPath

Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control

Not Applicable
Recruiting
Conditions
Inflammation Caused by the Placement of a Temporary Anchorage Device
Registration Number
NCT05639907
Lead Sponsor
University of Colorado, Denver
Brief Summary

To determine if coating miniscrews with K21 would increase the success rate of orthodontic miniscrews by reducing adjacent tissue inflammation.

Detailed Description

The study design is a split mouth study where 2 miniscrews, one pretreated with K21 the other pretreated (experimental) with ethanol (placebo) are placed in the mouth for orthodontic therapy. All participants will receive 2 or more orthodontic miniscrews with equal numbers of experimental and control pretreatment solutions. Mobility will be assessed at the 4 and 8 week follow up appointments by gentle manipulation with cotton pliers. Clinical success will be defined as maintenance of stability for a period of 8 weeks. Peri-implant inflammation will be assessed at follow up appointments by looking for signs of soft-tissue inflammation (redness, swelling) where possible.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Good general health, with no significant medical findings
  2. Requiring at least two miniscrews in their treatment plans (i.e., most participants will have two miniscrews, but some may receive four or six as indicated by their individual treatment plan)
  3. Miniscrew pairs indicated with comparable anatomical positions and comparable mechanics (direct vs. indirect anchorage).
Exclusion Criteria
  1. Recent or ongoing use of antiresorptive pharmacological agents contraindicating the use of orthodontic miniscrews
  2. Less than 12 years of age
  3. Heavy tobacco use (>10 cigarettes/day)
  4. Peri-implant tissues must be observable at follow-up appointments
  5. Being unable or unwilling to consent to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Peri-implant inflammation8 weeks

Inspection for signs of soft-tissue inflammation (redness, swelling) immediately around the TAD. The Loe-Silness Index scale will be used to assess any inflammation. The Loe-Silness Index scale is between 0 and 3 where a 0 is normal soft tissue, 1 is mild inflammation where the tissue color is slightly red and the tissue does not bleed upon probing, 2 is moderate inflammation where the tissue color is red with edema and bleeds upon probing, and 3 is severe inflammation where the tissue bleeds with little or no probing has edema and has ulcers.

TAD motility8 weeks

The motility of a TAD is evaluated by gentle manipulation with cotton pliers. Clinical failures will be defined as a mobility greater than or equal to 1mm. Clinical success will be defined as maintenance of stability for a period of 8 weeks.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado School of Dental Medicine

🇺🇸

Aurora, Colorado, United States

University of Colorado School of Dental Medicine
🇺🇸Aurora, Colorado, United States
Clifton Carey, PhD
Contact
303-724-1046
clifton.carey@cuanschutz.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.